Death-inducing receptors and apoptotic changes in lymphocytes of patients with heart transplant vasculopathy

Clinical and Experimental Immunology

Volumn 127, Issue 1, 2002, Pages 183-189

  Ankersmit, H J ^a,b   Moser, B ^a   Roedler, S ^a   Teufel, I ^a   Zuckermann, A ^a   Roth, G ^a   Lietz, K ^a   Back, C ^a   Gerlitz, S ^a   Wolner, E ^a   Boltz Nitulescu, G ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Apoptosis; CD95; CD95L; Heart allograft; TNFR1; Transplant associated coronary artery disease

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD56 ANTIGEN; FAS ANTIGEN; HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H4; INTERLEUKIN 10; LIPOCORTIN 5; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ALLOGRAFT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MALE; MEMORY CELL; NATURAL KILLER CELL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE;

AGED; ANTIGENS, CD45; ANTIGENS, CD95; CORONARY ARTERIOSCLEROSIS; FAS LIGAND PROTEIN; FEMALE; HEART TRANSPLANTATION; HUMANS; INTERLEUKIN-10; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036180725     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01741.x     Document Type: Article

References (34)

1. Cardiac allograft vasculopathy: A review
2. Cardiac transplant vasculopathy
3. Allograft vasculopathy: Diagnosing the nemesis of heart transplantation
4. Transplant atherosclerosis
5. Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopahty
6. Regulatory role of Th-2 cytokines, IL-10 and IL-4, in cardiac allograft rejection
7. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes
8. Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device
9. Impaired T cell function, increased soluble death-inducing receptors, and activation-induced T cell death in patients undergoing haemodialysis
10. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: Correlation with Bcl-2 expression and consequences for AIDS pathogenesis
11. Differential ability of T cell subsets to undergo activation-induced cell death
12. Regulatory cells potentiate the efficacy of IL-4 gene transfer by up-regulating Th2-dependent expression of protective molecules in the infectious tolerance pathway in transplant recipients
13. The apoptosis-1/Fas protein in human systemic lupus erythematosus
14. + T cells with lymphocyte activation and activity of disease in patients with primary Sjogren's syndrome
15. Decreased Th-1-like and increased Th2-like cells in systemic lupus erythematosus
16. Decreased production of interleukin 12 and other Th-1 type cytokines in patients with recent-onset systemic lupus erythematosus
17. CD95 (APO-1/Fas)-mediated apoptosis: Live and let die
18. A novel protein that interacts with the death domain of Fas/APO-1 contains a sequence motif related to the death domain
19. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
20. Interleukin-10
21. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II MHC expression
22. IL-10 augments CD23 expression on U937 cells and down-regulates IL-4-driven CD23 expression on cultured human blood monocytes: Effects of IL-10 and other cytokines on cell phenotype and phagocytosis
23. High levels of interleukin-10 production in vivo are associated with tolerance induction in SCID patients transplanted with HLA mismatched hematopoietic stem cells
24. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by over-expression of Bcl-2 and Abl
25. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
26. Induction of rapid histone degradation by the cytotoxic T lymphocyte protease granzyme A
27. Caspases and T-cell receptor-induced thymocyte apoptosis
28. Regulated commitment of TNF receptor signaling: A molecular switch for death or activation
29. The TNF and TNF receptor superfamilies. Integrating mammalian biology
30. Plasma concentrations of soluble tumor necrosis factor receptor I and tumor necrosis factor during cardiopulmonary bypass
31. Effects of a polymorphism in the human tumor necrosis factor alpha promotor on transcriptional activation
32. CD14 is a component of multiple regulation systems used by macrophages to phagocytose apoptotic lymphocytes
33. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopoysaccharide (LPS)-stimulated whole blood cell culture in healthy humans
34. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis